Psyence Biomedical (PBM) Competitors $0.07 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PBM vs. LIXT, ONCT, CPHI, IMCC, GHSI, MYMD, FRTX, PPBT, NCNA, and SNPXShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include Lixte Biotechnology (LIXT), Oncternal Therapeutics (ONCT), China Pharma (CPHI), IM Cannabis (IMCC), Guardion Health Sciences (GHSI), MyMD Pharmaceuticals (MYMD), Fresh Tracks Therapeutics (FRTX), Purple Biotech (PPBT), NuCana (NCNA), and Synaptogenix (SNPX). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. Lixte Biotechnology Oncternal Therapeutics China Pharma IM Cannabis Guardion Health Sciences MyMD Pharmaceuticals Fresh Tracks Therapeutics Purple Biotech NuCana Synaptogenix Lixte Biotechnology (NASDAQ:LIXT) and Psyence Biomedical (NASDAQ:PBM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends. Which has more risk and volatility, LIXT or PBM? Lixte Biotechnology has a beta of -0.17, suggesting that its stock price is 117% less volatile than the S&P 500. Comparatively, Psyence Biomedical has a beta of -0.42, suggesting that its stock price is 142% less volatile than the S&P 500. Which has better earnings & valuation, LIXT or PBM? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLixte BiotechnologyN/AN/A-$5.09M-$1.78-1.10Psyence BiomedicalN/AN/A-$51.16MN/AN/A Do institutionals & insiders have more ownership in LIXT or PBM? 5.1% of Lixte Biotechnology shares are held by institutional investors. Comparatively, 77.4% of Psyence Biomedical shares are held by institutional investors. 15.5% of Lixte Biotechnology shares are held by insiders. Comparatively, 3.6% of Psyence Biomedical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is LIXT or PBM more profitable? Psyence Biomedical's return on equity of 0.00% beat Lixte Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Lixte BiotechnologyN/A -5,562.77% -102.10% Psyence Biomedical N/A N/A N/A Does the media favor LIXT or PBM? In the previous week, Psyence Biomedical had 5 more articles in the media than Lixte Biotechnology. MarketBeat recorded 5 mentions for Psyence Biomedical and 0 mentions for Lixte Biotechnology. Psyence Biomedical's average media sentiment score of 0.16 beat Lixte Biotechnology's score of 0.00 indicating that Psyence Biomedical is being referred to more favorably in the news media. Company Overall Sentiment Lixte Biotechnology Neutral Psyence Biomedical Neutral Do analysts prefer LIXT or PBM? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lixte Biotechnology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/APsyence Biomedical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community believe in LIXT or PBM? Lixte Biotechnology and Psyence Biomedical both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformLixte BiotechnologyN/AN/APsyence BiomedicalN/AN/A SummaryPsyence Biomedical beats Lixte Biotechnology on 5 of the 8 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBM vs. The Competition Export to ExcelMetricPsyence BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.13M$6.75B$5.04B$8.43BDividend YieldN/A7.94%7.52%4.16%P/E RatioN/A12.17130.2316.67Price / SalesN/A270.431,720.2276.26Price / CashN/A46.0936.9133.54Price / Book-0.085.284.604.98Net Income-$51.16M$151.33M$114.94M$224.26M7 Day PerformanceN/A0.30%0.14%1.65%1 Month PerformanceN/A14.88%10.15%6.92%1 Year PerformanceN/A36.87%33.87%26.46% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMPsyence BiomedicalN/A$0.07flatN/AN/A$1.13MN/A0.00N/AGap DownLIXTLixte Biotechnology0.586 of 5 stars$2.02-4.3%N/A-32.7%$4.55MN/A-1.133ONCTOncternal Therapeutics2.4467 of 5 stars$1.50+2.7%$20.00+1,233.3%-79.2%$4.44M$790,000.00-0.1230Analyst ForecastHigh Trading VolumeCPHIChina PharmaN/A$0.26-0.8%N/A-46.1%$4.40M$7.01M0.00250IMCCIM Cannabis0.3683 of 5 stars$1.97-5.3%N/A-30.3%$4.40M$49.88M-0.51340Upcoming EarningsGHSIGuardion Health Sciences1.6271 of 5 stars$3.22-2.1%N/A-47.6%$4.35M$12.25M0.6610Upcoming EarningsGap DownMYMDMyMD PharmaceuticalsN/A$1.82+28.2%N/A-88.6%$4.31MN/A0.009Gap UpFRTXFresh Tracks TherapeuticsN/A$0.72flatN/A-18.9%$4.30M$8.01M-0.5120PPBTPurple Biotech2.6877 of 5 stars$3.11-3.1%$200.00+6,330.9%N/A$4.14MN/A-0.2420News CoverageNCNANuCana3.0546 of 5 stars$1.54-4.9%$25.00+1,523.4%-86.9%$4.07MN/A-0.1330Positive NewsSNPXSynaptogenix1.7233 of 5 stars$2.96-0.7%$14.00+373.0%-60.8%$4.01MN/A0.004Gap Down Related Companies and Tools Related Companies Lixte Biotechnology Alternatives Oncternal Therapeutics Alternatives China Pharma Alternatives IM Cannabis Alternatives Guardion Health Sciences Alternatives MyMD Pharmaceuticals Alternatives Fresh Tracks Therapeutics Alternatives Purple Biotech Alternatives NuCana Alternatives Synaptogenix Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PBM) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBM Stock Alerts